tiprankstipranks
Trending News
More News >
Omaxe Limited (IN:OMAXE)
:OMAXE
India Market
Advertisement

Omaxe Limited (OMAXE) AI Stock Analysis

Compare
0 Followers

Top Page

IN:OMAXE

Omaxe Limited

(OMAXE)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 4o)
Rating:43Neutral
Price Target:
₹94.00
▲(13.76% Upside)
The overall stock score is heavily impacted by Omaxe Limited's financial performance, characterized by significant losses and financial strain. Technical analysis indicates weak momentum, further weighing on the score. Valuation challenges due to negative earnings and no dividend yield contribute to a low overall score.

Omaxe Limited (OMAXE) vs. iShares MSCI India ETF (INDA)

Omaxe Limited Business Overview & Revenue Model

Company DescriptionOmaxe Limited engages in the real estate development activities in India. It develops and sells integrated and hi-tech townships, group housing projects, shopping malls, office spaces, SCOs, and hotels. The company was formerly known as Omaxe Construction Limited and changed its name to Omaxe Limited in June 2006. Omaxe Limited was founded in 1987 and is based in New Delhi, India. Omaxe Limited is a subsidiary of Guild Builders Private Limited.
How the Company Makes MoneyOmaxe Limited generates revenue primarily through the sale of residential and commercial properties. The company develops and sells residential units such as apartments, villas, and plots, as well as commercial properties including office spaces and retail outlets. Revenue is recognized upon the delivery of these properties to the customers. Additionally, Omaxe earns from leasing and renting out retail and commercial spaces, which provides a steady stream of income. Strategic partnerships with financial institutions and construction firms often facilitate project financing and operational efficiencies, contributing to the company's earnings. Omaxe also engages in joint ventures with landowners and other developers, sharing profits generated from these projects.

Omaxe Limited Financial Statement Overview

Summary
Omaxe Limited is experiencing significant financial strain with ongoing losses and high leverage. The negative equity and profitability challenges indicate serious financial risks, although cash flows provide some operational support.
Income Statement
25
Negative
Omaxe Limited has faced a challenging period with consistent losses. The net profit margin is negative, indicating a lack of profitability, and gross profit margins have also been negative, reflecting operational inefficiencies or cost challenges. Although there was some revenue growth over the years, it was insufficient to turn around the negative EBIT and EBITDA margins, pointing to ongoing operational difficulties.
Balance Sheet
20
Very Negative
The balance sheet reveals significant financial stress with a negative stockholders' equity in the latest report, indicating more liabilities than assets, which is a risk indicator. The debt-to-equity ratio is not calculable due to negative equity, but total debt levels remain high. Despite this, the company maintains a reasonable level of cash and short-term investments, providing some liquidity buffer.
Cash Flow
40
Negative
Cash flow analysis shows some strengths, with positive operating and free cash flow despite net income losses, indicating efficient cash management. However, free cash flow growth has been inconsistent and recently negative. The operating cash flow to net income ratio is positive, highlighting cash generation, but the ability to maintain this amid operating losses remains uncertain.
BreakdownTTMDec 2025Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue15.62B16.37B16.14B7.73B6.18B4.76B
Gross Profit-4.88B-4.11B-1.77B-929.60M601.70M21.90M
EBITDA-5.77B-5.32B-3.48B-2.76B-464.60M-971.60M
Net Income-6.83B-6.86B-4.03B-3.48B-1.60B-2.35B
Balance Sheet
Total Assets0.00148.77B138.22B135.60B119.18B110.42B
Cash, Cash Equivalents and Short-Term Investments5.78B10.95B5.40B7.39B1.28B1.06B
Total Debt0.007.96B6.79B11.07B10.43B14.57B
Total Liabilities-1.01B150.74B133.33B126.50B106.58B96.20B
Stockholders Equity1.01B-2.05B4.80B8.98B12.45B14.05B
Cash Flow
Free Cash Flow0.003.28B9.70B4.49B7.66B5.58B
Operating Cash Flow0.003.52B9.87B4.69B7.83B5.66B
Investing Cash Flow0.00-1.55B-640.20M-1.42B-221.50M227.20M
Financing Cash Flow0.00-863.50M-9.24B-2.62B-7.40B-5.17B

Omaxe Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price82.63
Price Trends
50DMA
92.30
Negative
100DMA
92.96
Negative
200DMA
90.96
Negative
Market Momentum
MACD
-1.89
Positive
RSI
32.08
Neutral
STOCH
19.43
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:OMAXE, the sentiment is Negative. The current price of 82.63 is below the 20-day moving average (MA) of 86.86, below the 50-day MA of 92.30, and below the 200-day MA of 90.96, indicating a bearish trend. The MACD of -1.89 indicates Positive momentum. The RSI at 32.08 is Neutral, neither overbought nor oversold. The STOCH value of 19.43 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:OMAXE.

Omaxe Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
15.03B18.705.69%5.44%5.27%
60
Neutral
2.37B59.385.26%157.16%29.79%
55
Neutral
39.35B32.211.93%52.02%
52
Neutral
16.40B34.9513.02%0.38%14.76%38.65%
43
Neutral
₹15.11B-13.87%-63.23%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:OMAXE
Omaxe Limited
82.63
-30.02
-26.65%
IN:ARIHANTSUP
Arihant Superstructures Limited
398.45
-20.52
-4.90%
IN:ATALREAL
Atal Realtech Limited
21.37
12.42
138.77%
IN:HUBTOWN
Hubtown Limited
290.20
-37.50
-11.44%
IN:PARSVNATH
Parsvnath Developers Limited
13.24
-5.27
-28.47%
IN:SHRIRAMPPS
Shriram Properties Ltd.
88.20
-39.20
-30.77%

Omaxe Limited Corporate Events

Omaxe Subsidiary Secures RERA Approval for Lucknow Project
Jun 30, 2025

Omaxe Limited has announced that its wholly-owned subsidiary, Omaxe Garv Buildtech Private Limited, has received a RERA Registration Certificate for its Metro City Phase 10 project in Lucknow, Uttar Pradesh. This regulatory approval enhances the project’s credibility, ensures compliance with real estate regulations, and allows the company to market and sell the project, which is expected to strengthen Omaxe’s brand value and positively impact its financial performance.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025